Codman & Shurtleff, Inc. (Codman), the global neurological device company, has received U.S. Food and Drug Administration (FDA) approval through a PMA supplement for its MEDSTREAM™ Programmable Infusion System, an implantable infusion pump and catheter system...
Engineers are able to probe the "hydraulics behind the headaches" and develop new diagnostic methods to detect which patients are most likely to benefit from surgery.
An estimated 40% of healthcare equipment in developing countries is out of service, compared with less than 1% in high-income countries. The inappropriate deployment of medical technologies from wealthy countries plays a major part in this high failure rate.
New tools have confirmed high rates of misdiagnosis of patients with chronic disorders of consciousness, such as the vegetative state.
When it comes to intelligence, what factors distinguish the brains of the exceptionally smart from those of average humans?
Concussions and even lesser head impacts may speed up the brain's natural aging process by causing signaling pathways in the brain to break down.
Brain-computer interfaces are at the cutting edge for treatment of neurological and psychological disorder, including Parkinson's, epilepsy, and depression.
A tiny vibrating cantilever sensor could soon help doctors and field clinicians quickly detect harmful toxins, bacteria and even indicators of certain types of cancer from small samples of blood or urine.
The innovative MEG-MRI device combines the whole-head magnetoencephalography (MEG) and magnetic resonance imaging (MRI) technology.
Researchers at Aalto University in Finland have developed the world's first device designed for mapping the human brain that combines whole-head magnetoencephalography (MEG) and magnetic resonance imaging (MRI) technology.
In one of the first studies to look at transcranial magnetic stimulation (TMS) in real-world clinical practice settings, researchers confirmed that it is an effective treatment for patients with depression.
Mazor Robotics wins FDA clearance to extend its Renaissance robotic platform into brain surgery. Mazor Robotics (PINK:MZRTF) won FDA clearance extending use of its Renaissance robotic system into brain surgery, the company announced this week.
The neurostimulation devices market can expect impressive gains over the next few years, as the global number of individuals with neurological conditions continues to rise, states a new report by healthcare experts GBI Research.
Today NeuroSigma, Inc., a Los Angeles-based medical device company, announced that it received ISO 13485: 2003 certification, indicating that it operates a Quality Management System for the design, manufacturing and distribution of its external Trigeminal Nerve Stimulation (eTNS™) system for the treatment of neurological and neuropsychiatric disorders.
The Penumbra System® family of aspiration thrombectomy devices now includes the MAX System of Reperfusion Catheters for removal of clots in patients experiencing acute ischemic stroke. The MAX System neuro-interventional devices offer a fast, simplified...
Spinal stimulation combined with assisted walking therapy generates new neural circuits and restores voluntary leg movement.
Neuroscientists at Cold Spring Harbor Laboratory (CSHL) reached an important milestone today, publicly releasing the first installment out of 500 terabytes of data so far collected in their pathbreaking project to construct the first whole-brain wiring diagram of a vertebrate brain...
In a step towards improving rehabilitation for patients with walking impairments, researchers from the Kennedy Krieger Institute found that non-invasive stimulation of the cerebellum, an area of the brain known to be essential in adaptive learning, helped healthy individuals...
It's the first study to show that brain chips can assist paralyzed people to perform complex real-world tasks.
A recently approved plaque-tracking dye can improve doctors' ability to identify Alzheimer's.
One pharmaceutical company aims to lengthen a stroke's drug-treatable period from hours to months.
In future a new magnetic sensor the size of a sugar cube might simplify the measurement of brain activity. In the magnetically shielded room of Physikalisch-Technische Bundesanstalt (PTB) the sensor has passed an important technical test: Spontaneous as well as stimulated...
Researchers led by Regenstrief Institute investigator Neale Chumbler, Ph.D., a research scientist with the Center of Excellence on Implementing Evidence-Based Practice at the Richard Roudebush VA Medical Center in Indianapolis, have developed STeleR...
Researchers from South Korea, Sweden, and the United States have collaborated on a project to restore neuron function to parts of the brain damaged by Huntington’s disease (HD) by successfully transplanting HD-induced pluripotent stem cells into animal models.
Xavant Technology, a medical device company specializing in the development and manufacturing of nerve stimulators, has launched a breakthrough nerve stimulator, the Stimpod NMS450.